CANC vs JDOC
Tema Oncology ETF against JPMorgan Healthcare Leaders ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
24%
12 shared positions
Fee gap
10 bp
JDOC is cheaper
1-year return gap
24.5 pts
CANC is ahead
Larger fund
CANC
$203M
Side by side
| CANC | JDOC | |
|---|---|---|
| Fund | Tema Oncology ETF | JPMorgan Healthcare Leaders ETF |
| Issuer | Tema | JPMorgan |
| Category | Biotech & Health Innovation | Health Care |
| Expense ratio | 0.75% | 0.65% |
| Assets | $203M | $9.1M |
| Average daily dollar volume | $1.3M | $14K |
| Listed | Aug 14, 2023 | Nov 1, 2023 |
| FrenzyCap score | 36 | 17 |
| 1-month return | −2.4% | −0.4% |
| 3-month return | −0.4% | −0.1% |
| Year to date | +17.5% | +4.7% |
| 1-year return | +36.2% | +11.7% |
| 30-day volatility | 21.4% | 13.3% |
| Worst drawdown, 1 year | −11.3% | −9.7% |
| Trailing 12-month yield | 0.05% | 0.85% |
| Holdings | 57 | 66 |
| Top 10 weight | 42.9% | 46.6% |
| Look-through P/E | — | 71.2 |
| Holdings vs fair value | +5.0% | +11.1% |
| Holdings above 200-day average | 61% | 71% |
| Net flow, latest 3 reported months | +$14M thru May 2026 | −$2.8M thru Jul 2026 |
| 30-day implied volatility | — | — |
| Holdings as of | as of May 31, 2026SEC filing | as of Apr 30, 2026SEC filing |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
37% of CANC · 37% of JDOC
Sector mix of the stock holdings
| Sector | CANC | JDOC | Gap |
|---|---|---|---|
| Health Care | 84.5% | 66.0% | +18.5% |
| Technology | 0.0% | 5.1% | −5.1% |
| Consumer Staples | 0.0% | 2.7% | −2.7% |
More: full overlap table · CANC holdings · JDOC holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.